lifestyle spending accounts glp-1 prescriptions weight management reimbursement Gross Medicare on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Loss The future of GLP-1s: Cost,

however, intra-LS Ex-4 with Ex-9 (at subthreshold doses) did not change chow intake, indicating GLP-1 in LS do not control ad libitum feeding

These include: Eggs are the single biggest culprit for most people

The arrival of oral Wegovy (Dec 2025) and generic liraglutide (Aug 2025) is expected to further shape pharmacy benefit coverage dynamics

Also, we are still learning a lot here, so there is more knowledge to come as time goes on! Whatever the results of further studies on natural GLP-1 agonists may be, small diet and lifestyle changes has the potential to significantly improve your overall health in the long run

Shayna Posses and Aaron Shattuck fact-check our show